scholarly article | Q13442814 |
P356 | DOI | 10.1001/JAMA.277.15.1224 |
P698 | PubMed publication ID | 9103347 |
P2093 | author name string | M S Anderson | |
D Blumenthal | |||
E G Campbell | |||
N Causino | |||
K S Louis | |||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1224-1228 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Withholding research results in academic life science. Evidence from a national survey of faculty | |
P478 | volume | 277 |
Q42227756 | "Get the Consent"-Nonfinancial Conflict of Interest in Academic Clinical Research |
Q35545776 | An Empirical Review of Major Legislation Affecting Drug Development: Past Experiences, Effects, and Unintended Consequences |
Q24544212 | Attacks on Science: The Risks to Evidence-Based Policy |
Q58106774 | Beyond financial conflicts of interest: Institutional oversight of faculty consulting agreements at schools of medicine and public health |
Q82821790 | Changing the rules of the game: addressing the conflict between free access to scientific discovery and intellectual property rights |
Q73196931 | Commercialisation of genetic diagnostic services |
Q28660837 | Commercialization and stem cell research: a review of emerging issues |
Q60517540 | Concerned Journals, Editors And ICMJE |
Q43187440 | Conflict of interest in biomedical publications |
Q34918959 | Conflicts of interest in drug development: the practices of Merck & Co., Inc. |
Q34159616 | DNA patents and scientific discovery and innovation: assessing benefits and risks |
Q56395033 | Data Sharing in Neurosurgery and Neurology Journals |
Q36417487 | Diagnostic testing fails the test |
Q34962859 | Do corresponding authors take responsibility for their work? A covert survey |
Q28752430 | Evidence and anecdotes: an analysis of human gene patenting controversies |
Q28755551 | Finer nuances of clinical study agreements for research trials |
Q52958926 | General Clinical Research Centers in the United States make a healthy recovery |
Q21144665 | Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry? |
Q27231434 | How Do Scientists Define Openness? Exploring the Relationship Between Open Science Policies and Research Practice |
Q34389549 | Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors |
Q36484339 | Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall? |
Q35372675 | Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature |
Q35121778 | Industry-university collaborations in Canada, Japan, the UK and USA--with emphasis on publication freedom and managing the intellectual property lock-up problem |
Q35559637 | Institutional ethics review of clinical study agreements |
Q35094791 | Intellectual property law: a primer for scientists |
Q83404901 | It’s About Scientific Secrecy, Dummy: A Better Equilibrium Among Genomics Patenting, Scientific Research and Health Care |
Q36381359 | Litigation-generated science: why should we care? |
Q55033893 | Location bias in controlled clinical trials of complementary/alternative therapies. |
Q42773769 | Maintaining the integrity of the scientific record |
Q42962752 | Managing conflict of interest: sense and sensibility |
Q35199601 | Mind, Brain and Psychotherapy |
Q37266348 | Non-publication of large randomized clinical trials: cross sectional analysis. |
Q53495160 | Normative orientations of university faculty and doctoral students |
Q49172685 | Patenting and licensing of university research: promoting innovation or undermining academic values? |
Q34185450 | Patenting human genetic material: refocusing the debate |
Q33895413 | Patenting of genetic material: are the benefits to society being realized? |
Q28654786 | Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey |
Q55301807 | Prepublication disclosure of scientific results: Norms, competition, and commercial orientation. |
Q52947431 | Psychiatrists and the pharmaceutical industry |
Q24549030 | Public availability of published research data in high-impact journals |
Q28742768 | Public sharing of research datasets: A pilot study of associations |
Q35890916 | Randomized clinical trials: what gets published, and when? |
Q24288789 | Reproducible Research Practices and Transparency across the Biomedical Literature |
Q74144024 | Scientific data from clinical trials: investigators' responsibilities and rights |
Q74231229 | Scientific data from clinical trials: investigators' responsibilities and rights |
Q94059466 | Scientific data from clinical trials: investigators' responsibilities and rights |
Q30690432 | Scientific data from clinical trials: investigators' responsibilities and rights |
Q28710576 | Sharing of clinical trial data among trialists: a cross sectional survey |
Q24554874 | Sponsorship, authorship and accountability |
Q74568328 | Sponsorship, authorship, and accountability |
Q58662706 | Surgical patents and patients--the ethical dilemmas |
Q24810516 | The benefits and threats of research partnerships with industry |
Q28606345 | The commercialization of university-based research: Balancing risks and benefits |
Q33296106 | The influence of personal and environmental factors on professionalism in medical education |
Q78085281 | The right answer for the wrong question: consequences of type III error for public health research |
Q34159801 | Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues |
Q28476002 | Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis |
Q48771401 | Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation |
Q35587396 | What do we really know about conflicts of interest in biomedical research? |
Q28742671 | Who Shares? Who Doesn't? Factors Associated with Openly Archiving Raw Research Data |
Search more.